Cargando…
Clinical and Immunologic Efficacy of the Recombinant Adenovirus Type-5-Vectored (CanSino Bio) Vaccine in University Professors during the COVID-19 Delta Wave
Information regarding the efficacy of the recombinant adenovirus type-5-vectored (CanSino Bio) vaccine against the COVID-19 disease in a real-life setting is limited. A retrospective cohort study was carried out in the teaching university community of the metropolitan area of Monterrey, Mexico, thro...
Autores principales: | Guzmán-López, Santos, Darwich-Salazar, Armine, Bocanegra-Ibarias, Paola, Salas-Treviño, Daniel, Flores-Treviño, Samantha, Pérez-Alba, Eduardo, Nuzzolo-Shihadeh, Laura M., Pérez-Rodríguez, Edelmiro, Camacho-Ortiz, Adrián |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143224/ https://www.ncbi.nlm.nih.gov/pubmed/35632412 http://dx.doi.org/10.3390/vaccines10050656 |
Ejemplares similares
-
CanSino COVID-19 Vaccine: Comparison of Vaccine Adverse Effects Among Diabetic and Non-diabetic Recipients
por: Abualhamael, Shahad Abduljalil, et al.
Publicado: (2023) -
Efficacy and Safety of Heterologous Booster Vaccination after Ad5-nCoV (CanSino Biologics) Vaccine: A Preliminary Descriptive Study
por: Muñoz-Valle, José Francisco, et al.
Publicado: (2022) -
Frequency of facial touching in patients with suspected COVID-19 during their time in the waiting room
por: Perez-Alba, Eduardo, et al.
Publicado: (2020) -
Prevalence of SARS-CoV-2 Variants of Concern and Variants of Interest in COVID-19 Breakthrough Infections in a Hospital in Monterrey, Mexico
por: Galán-Huerta, Kame A., et al.
Publicado: (2022) -
Hospitalization and risk of death due to influenza among vaccinated and unvaccinated patients. A 5-year study in the northeastern Mexican population
por: Nuzzolo-Shihadeh, Laura, et al.
Publicado: (2022)